Intima Bioscience

New York, United States Founded: 2014 • Age: 12 yrs
Therapeutics for gastrointestinal cancer are developed using CRISPR gene-editing.

About Intima Bioscience

Intima Bioscience is a Healthcare company based in New York (United States) founded in 2014. Therapeutics for gastrointestinal cancer are developed using CRISPR gene-editing. Intima Bioscience offers products and services including Checkpoint Cell Therapy and Tumor Infiltrating Lymphocytes (TIL). Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms. Its legal entity is Intima Bioscience, Inc. Similar companies include eGenesis, Beam Therapeutics and Korro Bio; 3 of its 3 listed similar companies have raised funding.

Company details

Intima Bioscience was founded in 2014 in New York, United States, within the biotechnology sector. A gene and cell therapeutic platform is being developed for gastrointestinal cancer treatment. Clinical trials are underway, with experiments conducted via the Molecular and Cell Therapy (MCT) GMP manufacturing platform. CRISPR technology is employed to engineer neoantigen-specific tumor-infiltrating lymphocytes that inhibit the intracellular immune checkpoint CISH.

  • Headquarters New York, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website intimabioscience.com
  • Legal Name Intima Bioscience, Inc

Products & Services of Intima Bioscience

Intima Bioscience offers a comprehensive portfolio of products and services, including Checkpoint Cell Therapy and Tumor Infiltrating Lymphocytes (TIL).

Checkpoint Cell Therapy
Gene Therapy

Uses CRISPR to edit T cells for inhibiting immune checkpoints in cancers

Tumor Infiltrating Lymphocytes (TIL)
Immunotherapy

Genetically engineered lymphocytes for treating solid tumor cancers

Similar companies to Intima Bioscience

Intima Bioscience has 3 listed similar companies in our database, 3 of them funded. They include eGenesis, Beam Therapeutics and Korro Bio.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
egenesisbio.com2015Cambridge, United States$481.42M94
Gene transplantation platform for humanizing pig cells is developed.
beamtx.com2017Cambridge, United States$222M340
Developer of gene therapy using CRISPR base editing to treat diseases
korrobio.com2018Cambridge, United States$4M77
RNA-editing technologies are provided for precision medicine applications.
Premium access

Detailed similar companies of Intima Bioscience

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Intima Bioscience

The website of Intima Bioscience (intimabioscience.com) receives about 3K visits a month.

  • Monthly visits
    3K

    ▲ 496.6% vs previous month

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Intima Bioscience (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Intima Bioscience

Premium access

Complete news archive for Intima Bioscience

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Intima Bioscience

Intima Bioscience was founded in 2014.

Intima Bioscience is headquartered in New York, United States. It is registered at New York, New York, United States.

Intima Bioscience was founded in 2014 in New York, United States, within the biotechnology sector. A gene and cell therapeutic platform is being developed for gastrointestinal cancer treatment. Clinical trials are underway, with experiments conducted via the Molecular and Cell Therapy (MCT) GMP manufacturing platform. CRISPR technology is employed to engineer neoantigen-specific tumor-infiltrating lymphocytes that inhibit the intracellular immune checkpoint CISH.

Intima Bioscience's top competitors include eGenesis, Korro Bio and Beam Therapeutics.

Intima Bioscience offers Checkpoint Cell Therapy and Tumor Infiltrating Lymphocytes (TIL).

Intima Bioscience operates through Intima Bioscience, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available